Related Experiment Video
Updated: Jul 5, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Potent triazolyl-proline-based inhibitors of HCV NS3 protease
Julie Naud1, Christopher Lemke, Nathalie Goudreau
1Boehringer Ingelheim (Canada) Ltd, Research and Development, 2100 rue Cunard, Laval, QC, Canada.
Abstract:
The design and synthesis of tripeptide-based inhibitors of the HCV NS3 protease containing a novel P2-triazole is described. Replacement of the P2 quinoline with a triazole moiety provided a versatile handle which could be expediently modified to generate a diverse series of inhibitors. Further refinement by the incorporation of an aryl-substituted triazole and replacement of the P1 acid with an acyl sulfonamide ultimately provided inhibitors with interesting cellular activity.
More Related Videos
10:16High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Dipeptidyl Peptidase 4 Inhibitors
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Antiprotozoal Agents